The presence of tumor-associated lymphocytes in a TNBC generated a gene expression profile that had increased expression of immune checkpoint regulators such as PD1, PD-L1 and CTLA4, strongly correlated with the IM gene signature centroid and was associated with increased relapse-free survival for the patient. The gene discussed is CTLA4; the disease is neoplasm.